The 786-O RCC line is defective in VHL expression, as it harbors mutated VHL [53, 54] with altered HIF and VEGF (Vascular endothelial growth factor) pathways [46] and gives rise to clear cell tumors in nude mice [55, 56]. Here, VHL is linked to renal cell adenocarcinoma.